bg
B

Bioatla (BCAB)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Bioatla (BCAB)

BioAtla, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

  • USD0.40
  • USD0.40
  • USD0.38
  • USD2.53
  • -23.60%
  • 11M
  • 631.76k
  • 551.07k
  • 22M
  • 0.24
  • -66.90%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.